The first iPRIME Symposium occurred on April 18th, 2023 with great success. This program in Prominence to Preeminence, with support from the Vice President for Research at UVA showcased our successes in supporting their research. Over 60 attendees heard great … Read More
The immunology, imaging, informatics Precision ImmunoMedicine (iPRIME) initiative announces our iPRIME Fellowship Awards. This award will support innovative collaborative projects between students in biological and medical sciences and students in data science. Proposals may budget up to $15,000 and stipend … Read More
Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells. They recently met in NYC with the … Read More
We are excited to announce that two of the Co-PI’s of the iPRIME initiative, Dr. Coleen McNamara and Dr. Angela Taylor, have received a Leducq International Network of Excellence Award. They, along with other experts, will us this prestigious CHECKPOINT … Read More
Due to the sad events on Sunday, the iPRIME Launch Symposium on November 15 will be cancelled. We hope to reschedule at a future date.
We are excited to welcome Dr. Antonio Abbate to the University of Virginia School of medicine Cardiovascular Research Center. Dr. Abbate is one of the world’s leading experts in precision Immunomedicine. Welcome to UVA, Dr. Abbate! Dr. Antonio Abbate joined … Read More
iPRIME Investigators have partnered with colleagues from the La Jolla Institute (LJI) to utilize single cell multi-omic analysis of human circulating immune cells to identify the B cell subtype in humans that is associated with IgE sensitization to alpha gal … Read More
The research project seeks to understand the effects of IgE to alpha-gal on atherosclerotic plaque development and define immune mechanisms mediating IgE sensitization to alpha-gal linked to atherosclerotic cardiovascular disease in mice and humans. As part of the iPRIME initiative, … Read More
Dr. Mike Brown of the Carter Immunology Center received $252,434 for his project “Risky variants in human cardiovascular disease” to study the role of Glucocorticoid-induced TNFR-related protein (GITR), an immune modulator of inflammation and Ox40, a T-cell receptor, and their … Read More